NOTIFICATION OF LATE FILING
(Check One):
[ } Form 10-K [ ] Form 11-K
[ ]
Form 20-F [X] Form 10-Q
[ ] Form 10-N-SAR
For Period Ended: September 30, 2000
[ ]
Transition Report on Form 10-K
[ ]
Transition Report on Form 10-Q
[ ]
Transition Report on Form 20-F
[ ]
Transition Report on Form 11-K
[ ]
Transition Report on Form N-SAR
For the Transition Period Ended:
Nothing in this form shall be construed to imply that
the Commission has verified any information contained herein.
If the notification relates to a portion of the filing
checked above, identify the Item(s) to which the notification relates:
Part I - Registrant Information
Full Name of Registrant: SANGSTAT MEDICAL CORPORATION
Former Name If Applicable:
Not applicable
6300 Dumbarton Circle
Fremont, California 94555
(Address of Principal Executive Offices including Zip Code)
Part II - Rules 12b-25 (b) and (c)
If the subject report could not be filed without
unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the
following should be completed. (Check appropriate box)
[X]
(a)
The reasons described in reasonable detail in Part III of this
form could not be eliminated without unreasonable effort or
expense;
[ ]
(b)
The subject annual report, semi-annual report, transition
report on Form 10-K, 20-F, 11-K or Form N-SAR, or portion thereof
will be filed on or before the 15th calendar day following the
prescribed due date; or the subject quarterly report of
transition report on Form 10-Q, or portion thereof will be filed
on or before the fifth calendar day following the prescribed due
date; and
[ ]
(c)
The accountant's statement or other exhibit required by
Rule 12b-25(c) has been attached if applicable.
Part III - Narrative
State below in reasonable detail the reasons why
Form 10-K, 11-K, 20-F, 10-Q, N-SAR or the transition report portion thereof could not be filed
within the prescribed time period. (Attach extra sheets if needed.)
The Company was informed by its filing service immediately prior to the deadline for filing its Quarterly
Report on Form 10-Q that the service would be unable to process an exhibit to the Form 10-Q in a timely manner for
filing. As a result, the Company was unable to file such exhibit with its Form 10-Q by November 14, 2000, the
required filing date, without unreasonable effort or expense. The Company did, however, file the body of the report
without the exhibit and undertakes to file an amendment to such Form 10-Q in compliance with Rule 12b-25 to
incorporate such exhibit.
Part IV - Other Information
(1) Name and telephone number of person to contact in regard to
this notification.
Carole L. Nuechterlein (510) 789-4300
Vice President and General Counsel
(2) Have all other periodic reports required under Section 13
or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the
Investment Company Act of 1940 during the preceding 12 months or for such
shorter period that the registrant was required to file such report(s) been
filed? If the answer is no, identify report(s).
[X] Yes
[ ] No
(3) Is it anticipated that any significant
change in results of operations from the corresponding period for the last fiscal year will be
reflected by the earnings statements to be included in the subject report or portion thereof?
[ ] Yes
[X] No
If so, attach an explanation of the
anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons
why a reasonable estimate of the results cannot be made.
SANGSTAT MEDICAL CORPORATION
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this notification to be signed on its behalf by the
undersigned hereunto duly authorized.
Date: November 15, 2000
|
|
| |
|
| |
Stephen G. Dance
|
| |
Senior Vice President, Finance
|
